These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12595862)

  • 1. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia.
    Blum A; Lang N; Peleg A; Vigder F; Israeli P; Gumanovsky M; Lupovitz S; Elgazi A; Ben-Ami M
    Am Heart J; 2003 Feb; 145(2):e7. PubMed ID: 12595862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.
    Greany KA; Nettleton JA; Wangen KE; Thomas W; Kurzer MS
    Eur J Clin Nutr; 2008 Dec; 62(12):1419-25. PubMed ID: 17805230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.
    Blum A; Hathaway L; Mincemoyer R; Schenke WH; Kirby M; Csako G; Waclawiw MA; Panza JA; Cannon RO
    J Am Coll Cardiol; 2000 Feb; 35(2):271-6. PubMed ID: 10676669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability.
    Törmälä R; Appt S; Clarkson TB; Mueck AO; Seeger H; Mikkola TS; Ylikorkala O
    Climacteric; 2008 Oct; 11(5):409-15. PubMed ID: 18781486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of soy isoflavones on endothelial function in healthy postmenopausal women.
    Colacurci N; Chiàntera A; Fornaro F; de Novellis V; Manzella D; Arciello A; Chiàntera V; Improta L; Paolisso G
    Menopause; 2005; 12(3):299-307. PubMed ID: 15879919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
    Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of soy protein beverages on serum cell adhesion molecule concentrations in prehypertensive/stage 1 hypertensive individuals.
    Dettmer M; Alekel DL; Lasrado JA; Messina M; Carriquiry A; Heiberger K; Stewart JW; Franke W
    J Am Coll Nutr; 2012 Apr; 31(2):100-10. PubMed ID: 22855915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women.
    Steinberg FM; Guthrie NL; Villablanca AC; Kumar K; Murray MJ
    Am J Clin Nutr; 2003 Jul; 78(1):123-30. PubMed ID: 12816781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Woo J
    J Hypertens; 2013 Feb; 31(2):384-92. PubMed ID: 23203140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women.
    Nasca MM; Zhou JR; Welty FK
    Am J Cardiol; 2008 Jul; 102(1):84-6. PubMed ID: 18572041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
    Zanger D; Yang BK; Ardans J; Waclawiw MA; Csako G; Wahl LM; Cannon RO
    J Am Coll Cardiol; 2000 Nov; 36(6):1797-802. PubMed ID: 11092646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome.
    Azadbakht L; Kimiagar M; Mehrabi Y; Esmaillzadeh A; Hu FB; Willett WC
    Diabetes Care; 2007 Apr; 30(4):967-73. PubMed ID: 17392557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy.
    West SG; Hilpert KF; Juturu V; Bordi PL; Lampe JW; Mousa SA; Kris-Etherton PM
    J Womens Health (Larchmt); 2005 Apr; 14(3):253-62. PubMed ID: 15857272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
    Cicinelli E; Ranieri G; Maffei S; Colafiglio G; Ria R; Bellavia M; Schonauer MM
    Fertil Steril; 2006 Oct; 86(4):899-904. PubMed ID: 16963035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial.
    Tabibi H; Hakeshzadeh F; Hedayati M; Malakoutian T
    J Ren Nutr; 2011 Nov; 21(6):485-91. PubMed ID: 21439850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women.
    Farzati A; Esposito K; Colacurci N; Fornaro F; Chiantera V; Farzati B
    Fertil Steril; 2002 Mar; 77(3):476-80. PubMed ID: 11872198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
    Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
    J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
    Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
    Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.